{
    "2020-05-31": [
        [
            {
                "time": "",
                "original_text": "爱情价多高？疫苗大佬离婚：235亿分手费创A股记录",
                "features": {
                    "keywords": [
                        "疫苗",
                        "大佬",
                        "离婚",
                        "分手费",
                        "A股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "康泰生物实控人前妻分235亿，创A股最贵离婚！网友：离婚卖股？",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "实控人",
                        "离婚",
                        "A股",
                        "卖股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物(300601.SZ)：因解除婚姻关系 杜伟民拟将23.99%的股份分割过户至袁莉萍名下",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "杜伟民",
                        "股份分割",
                        "婚姻关系"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "5月83股创历史新高，还有16股年内翻倍，这两大行业成牛股集中营",
                "features": {
                    "keywords": [
                        "历史新高",
                        "牛股",
                        "行业"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "未指定"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "康泰生物：股权激励达成有“诀窍”",
                "features": {
                    "keywords": [
                        "康泰生物",
                        "股权激励",
                        "诀窍"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【民生医药|周报】CXO表现较好，推荐景气提升细分领域配置价值",
                "features": {
                    "keywords": [
                        "民生医药",
                        "CXO",
                        "景气提升",
                        "配置价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}